Picker wins ruling in ISO case
Picker International hopes a federal court judge's ruling thismonth has ended its eight-year legal battle with independent serviceorganization Imaging Equipment Services (IES) of Pittsburgh. Picker filed the litigation in 1987, accusing IES of
Picker International hopes a federal court judge's ruling thismonth has ended its eight-year legal battle with independent serviceorganization Imaging Equipment Services (IES) of Pittsburgh.
Picker filed the litigation in 1987, accusing IES of improperuse of service software and other charges. IES in turn chargedPicker with antitrust violations relating to scanner service.
Picker won a summary judgment ruling last year that threw outmany of the IES accusations (SCAN 6/15/94). In a ruling this month,U.S. District Court Judge Mark Wolf rejected the last of the ISO'scharges relating to intellectual property and issued a stingingrebuke to IES.
In a 73-page opinion, Wolf said IES "engaged in a relentlessand extensive campaign to misappropriate Picker's legally protectedintellectual property."
Wolf ordered IES to return or destroy Picker diagnostic softwareand service and repair documentation in its possession and permanentlyenjoined IES from violating Picker copyrights or misappropriatingPicker trade secrets. The judge appointed a monitor to ensurethat IES complies with the court's order.
A Picker spokesperson said the Cleveland vendor hopes thatWolf's ruling will be the last word on the case. IES plans toappeal the ruling to the U.S. Court of Appeals, according to IEScounsel Bill West.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
